Browse by:

Discovery Museum, MathWorks renew STEM partnership

Grant Welker |

The Discovery Museum in Acton and Natick's MathWorks have renewed their long-running program bringing STEM education to classrooms across the region.

Transportation commission still being formed

State House News Service |

In September, Lt. Gov. Karyn Polito announced that Gov. Charlie Baker would sign an executive order "in the coming weeks" creating a new commission to review transportation needs and how the state...

WPI researchers develop 'sperm sorting' device

A group of researchers at Worcester Polytechnic Institute and Stanford University have developed a device that selects faster, healthier sperm to be used during in vitro fertilization.

Biostage closes $4.2M investment with Chinese group, Conn. hospital

Zachary Comeau |

Holliston-based Biostage announced Wednesday the closing of a $4.2-million private investment primarily with a Chinese investment group and a Connecticut children's hospital.

Littleton radiation treatment firm gets FDA clearance for new proton therapy system

Zachary Comeau |

Littleton radiation treatment firm Mevion Medical Systems has received federal clearance for a new proton therapy treatment system.

Virtual reality company brings innovative tech to Marlborough

Mindtrek VR, a virtual reality gaming company, in December opened its second Massachusetts location with a 4,000-square-foot space in Marlborough's Apex Center.

Can freezing eggs freeze time?

Susan Shalhoub |

There are more local options for women when it comes to issues of timing, such as the retrieval, freezing and preservation of ovarian eggs for later fertilization.

TJX recommends rejection of mini-tender

Grant Welker |

Retailer TJX is recommending that its shareholders reject an unsolicited offer below market price.

Framingham/Worcester commuter line improves reliability

Grant Welker |

The rail line's 30-day average as of Wednesday was 94 percent, finally catching up to the MBTA system average after a less-than-stellar year.

Biostage combines stock 20:1 to satisfy $4M private investor

Zachary Comeau |

In order to complete a $4-million deal with a private investor and save the company from insolvency, Holliston biotech Biostage has performed a 20:1 reverse stock split.

Copyright 2017 New England Business Media